COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study

Initial studies that described the novel coronavirus (COVID-19) reported increased morbidity and mortality in patients with cancer. Of this group, patients with hematologic malignancies (HM) had the highest disease severity and death rates. Subsequent studies have attempted to better describe how CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xuejun Alice, Binder, Adam F., Gergis, Usama, Wilde, Lindsay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581235/
https://www.ncbi.nlm.nih.gov/pubmed/34778057
http://dx.doi.org/10.3389/fonc.2021.740320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581235/
https://www.ncbi.nlm.nih.gov/pubmed/34778057
http://dx.doi.org/10.3389/fonc.2021.740320

Ejemplares similares